T1	Participants 436 631	Premenstrual women with laparoscopically diagnosed endometriosis who required GnRH agonist therapy for treatment and did not have significant depressive or premenstrual mood symptoms at baseline.
T2	Participants 648 801	Participants were randomly assigned to either the sertraline treatment group or to the placebo group for the 3-month duration of the GnRH agonist therapy
T3	Participants 1158 1260	sertraline treatment group manifesting significantly fewer depressive symptoms than the control group.
